These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

829 related articles for article (PubMed ID: 27063391)

  • 1. Institutional Cost Comparison Between Heart Transplants and Left Ventricular Assist Device Implantations.
    Chimanji N; Kilic A; Hasan A; Higgins RS; Whitson BA; Kilic A
    Exp Clin Transplant; 2016 Dec; 14(6):656-659. PubMed ID: 27063391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost comparison of heart transplant vs. left ventricular assist device therapy at one year.
    Marasco SF; Summerhayes R; Quayle M; McGiffin D; Luthe M
    Clin Transplant; 2016 May; 30(5):598-605. PubMed ID: 26913688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Orthotopic heart transplant versus left ventricular assist device: a national comparison of cost and survival.
    Mulloy DP; Bhamidipati CM; Stone ML; Ailawadi G; Kron IL; Kern JA
    J Thorac Cardiovasc Surg; 2013 Feb; 145(2):566-73; discussion 573-4. PubMed ID: 23246055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Postcardiac transplant survival in the current era in patients receiving continuous-flow left ventricular assist devices.
    Kamdar F; John R; Eckman P; Colvin-Adams M; Shumway SJ; Liao K
    J Thorac Cardiovasc Surg; 2013 Feb; 145(2):575-81. PubMed ID: 23321132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-effectiveness of ventricular assist device therapy as a bridge to transplantation compared with nonbridged cardiac recipients.
    Alba AC; Alba LF; Delgado DH; Rao V; Ross HJ; Goeree R
    Circulation; 2013 Jun; 127(24):2424-35. PubMed ID: 23697907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness of left ventricular assist devices (LVADs) for patients with advanced heart failure: analysis of the British NHS bridge to transplant (BTT) program.
    Clarke A; Pulikottil-Jacob R; Connock M; Suri G; Kandala NB; Maheswaran H; Banner NR; Sutcliffe P
    Int J Cardiol; 2014 Feb; 171(3):338-45. PubMed ID: 24424339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of bridge-to-transplant ventricular assist device support on survival after cardiac transplantation.
    Bull DA; Reid BB; Selzman CH; Mesley R; Drakos S; Clayson S; Stoddard G; Gilbert E; Stehlik J; Bader F; Kfoury A; Budge D; Eckels DD; Fuller A; Renlund D; Patel AN
    J Thorac Cardiovasc Surg; 2010 Jul; 140(1):169-73. PubMed ID: 20451930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost of 1-year left ventricular assist device destination therapy in chronic heart failure: a comparison with heart transplantation.
    Droogne W; Jacobs S; Van den Bossche K; Verhoeven J; Bostic RR; Vanhaecke J; Van Cleemput J; Rega F; Meyns B
    Acta Clin Belg; 2014 Jun; 69(3):165-70. PubMed ID: 24820923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved survival and decreasing incidence of adverse events with the HeartMate II left ventricular assist device as bridge-to-transplant therapy.
    John R; Kamdar F; Liao K; Colvin-Adams M; Boyle A; Joyce L
    Ann Thorac Surg; 2008 Oct; 86(4):1227-34; discussion 1234-5. PubMed ID: 18805167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative survival and cost-effectiveness of advanced therapies for end-stage heart failure.
    Long EF; Swain GW; Mangi AA
    Circ Heart Fail; 2014 May; 7(3):470-8. PubMed ID: 24563450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Left Ventricular Device Implantation Impacts on Hospitalisation Rates, Length of Stay and Out of Hospital Time.
    Prichard R; Kershaw L; Goodall S; Davidson P; Newton P; McNeil F; Homer T; Hayward C
    Heart Lung Circ; 2018 Jun; 27(6):708-715. PubMed ID: 28888837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiac replacement therapies: outcomes and costs for heart transplantation versus circulatory assist.
    Mishra V; Fiane AE; Winsnes BA; Geiran O; Sørensen G; Hagen TP; Gude E
    Scand Cardiovasc J; 2017 Feb; 51(1):1-7. PubMed ID: 27248460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of end-stage heart failure patients with or without ventricular assist device: an observational comparison of clinical and economic outcomes.
    Aissaoui N; Morshuis M; Maoulida H; Salem JE; Lebreton G; Brunn M; Chatellier G; Hagège A; Schoenbrodt M; Puymirat E; Latremouille C; Varnous S; Ouldamar S; Guillemain R; Diebold B; Guedeney P; Barreira M; Mutuon P; Guerot E; Paluszkiewicz L; Hakim-Meibodi K; Schulz U; Danchin N; Gummert J; Durand-Zaleski I; Leprince P; Fagon JY
    Eur J Cardiothorac Surg; 2018 Jan; 53(1):170-177. PubMed ID: 28950304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implantable left ventricular assist device. Approaching an alternative for end-stage heart failure. Implantable LVAD Study Group.
    McCarthy PM; James KB; Savage RM; Vargo R; Kendall K; Harasaki H; Hobbs RE; Pashkow FJ
    Circulation; 1994 Nov; 90(5 Pt 2):II83-6. PubMed ID: 7955290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bridge with a left ventricular assist device to a simultaneous heart and kidney transplant: Review of the United Network for Organ Sharing database.
    Gaffey AC; Chen CW; Chung J; Grandin EW; Porrett PM; Acker MA; Atluri P
    J Card Surg; 2017 Mar; 32(3):209-214. PubMed ID: 28176387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Healthcare Resource Use and Cost Implications in the MOMENTUM 3 Long-Term Outcome Study.
    Mehra MR; Salerno C; Cleveland JC; Pinney S; Yuzefpolskaya M; Milano CA; Itoh A; Goldstein DJ; Uriel N; Gulati S; Pagani FD; John R; Adamson R; Bogaev R; Thohan V; Chuang J; Sood P; Goates S; Silvestry SC
    Circulation; 2018 Oct; 138(18):1923-1934. PubMed ID: 29807933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Durable left ventricular assist device support as a bridge to heart transplant candidacy†.
    Shaw SM; Venkateswaran R; Hogg R; Rushton S; Al-Attar N; Schueler S; Lim S; Parameshwar J; Banner NR
    Interact Cardiovasc Thorac Surg; 2019 Apr; 28(4):594-601. PubMed ID: 30351360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative cost-effectiveness of the HeartWare versus HeartMate II left ventricular assist devices used in the United Kingdom National Health Service bridge-to-transplant program for patients with heart failure.
    Pulikottil-Jacob R; Suri G; Connock M; Kandala NB; Sutcliffe P; Maheswaran H; Banner NR; Clarke A
    J Heart Lung Transplant; 2014 Apr; 33(4):350-8. PubMed ID: 24582838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Left ventricular assist devices as destination therapy: a new look at survival.
    Park SJ; Tector A; Piccioni W; Raines E; Gelijns A; Moskowitz A; Rose E; Holman W; Furukawa S; Frazier OH; Dembitsky W
    J Thorac Cardiovasc Surg; 2005 Jan; 129(1):9-17. PubMed ID: 15632819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Costs and Outcomes in the Care of Bi-ventricular Support as a Bridge to Cardiac Transplant.
    Swartz MF; Angona R; Smith K; Kraenzlin F; Stypula CM; Joshi D; Tchantchaleishvili V; Hicks GL; Massey HT
    ASAIO J; 2016; 62(5):513-7. PubMed ID: 27258229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 42.